NCT06223659View on ClinicalTrials.gov

EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 19, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cutaneous MelanomaMerkel Cell CarcinomaSkin Squamous Cell Carcinoma
Interventions
DRUG

Eutectic Mixture of Local Anesthetics

Apply topically to skin

DRUG

Placebo Administration

Apply topically to skin

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

43210

RECRUITING

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER